Standard BioTools Total Assets 2010-2025 | LAB

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Standard BioTools total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Standard BioTools total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$46.9B
Hims & Hers Health (HIMS)	$14.7B
Doximity (DOCS)	$11.1B
Tempus AI (TEM)	$10B
IRhythm Technologies (IRTC)	$4.5B
Inspire Medical Systems (INSP)	$3.9B
Hinge Health (HNGE)	$3.5B
Privia Health (PRVA)	$2.4B
10x Genomics (TXG)	$1.7B
Phreesia (PHR)	$1.6B
Enovis (ENOV)	$1.5B
Azenta (AZTA)	$1.5B
Schrodinger (SDGR)	$1.5B
Clover Health Investments (CLOV)	$1.5B
Omnicell (OMCL)	$1.4B
Evolent Health (EVH)	$1.2B
Claritev (CTEV)	$636M
Fulgent Genetics (FLGT)	$532M
Veradigm (MDRX)	$507M
Butterfly Network (BFLY)	$448M
Talkspace (TALK)	$418M
TruBridge (TBRG)	$315M
Outset Medical (OM)	$300M
Health Catalyst (HCAT)	$256M
Nyxoah SA (NYXH)	$243M
SOPHiA GENETICS SA (SOPH)	$212M
CapsoVision (CV)	$190M
Zepp Health (ZEPP)	$175M
KORU Medical Systems (KRMD)	$161M
Pulmonx (LUNG)	$127M